Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration Resistant Prostate Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Lethal prostate cancer (PCa) evolves independently across metastatic sites, with most genetic changes occurring after spread. This highlights the need for multi-site analysis in cancer diagnostics and therapy.
Area Of Science
- Genomics
- Evolutionary Biology
- Oncology
Background
- Lethal prostate cancer (PCa) undergoes evolutionary bottlenecks, including metastasis and castration resistance.
- Understanding genetic heterogeneity across metastatic sites is crucial for developing effective treatment strategies.
Purpose Of The Study
- To investigate patterns of metastatic dissemination and clonal evolution in lethal prostate cancer.
- To characterize the genetic landscape of PCa across multiple metastatic sites within individual patients.
Main Methods
- Deep whole-exome sequencing of 93 tumors from 26 patients.
- Phylogenetic reconstruction and mathematical modeling to analyze clonal evolution and mutation patterns.
Main Results
- Most mutations, copy-number alterations, and clones arose independently within individual metastatic sites after initial cancer spread.
- Polyclonal and polyphyletic seeding contributed to the heterogeneity of metastatic lesions.
- Single-tissue sequencing can overestimate clonality and underestimate mutation rates.
Conclusions
- Metastatic lesions in prostate cancer evolve independently, driven by polyclonal seeding.
- These findings have significant implications for the interpretation of diagnostic data and the development of targeted therapies.
- Multi-site tumor sequencing is essential for a comprehensive understanding of PCa evolution and for guiding treatment decisions.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...